Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program

Rocket Pharmaceuticals is a Buy, with strong catalysts, undervalued programs, and significant upside. Click here to read my ...

Why Omeros (OMER) Is Up 74.0% After First-In-Class TA-TMA Drug Wins FDA Approval

Earlier this month, Omeros Corporation announced that the FDA approved YARTEMLEA (narsoplimab-wuug), the first and only therapy for hematopoietic stem cell transplant-associated thrombotic ...

FDA Infant Formula Warning Could Be A Game Changer For Walmart’s (WMT) Tech-Driven Retail Strategy

In recent weeks, Walmart has faced an FDA warning letter over recalled ByHeart infant formula remaining on sale in dozens of its stores, even as it expands branded offerings like Dove x Crumbl ...
Scientific Research Publishing

Reinforcement Learning for Antidepressant Dose Adjustment: An Explainable Agent Approach ()

Reinforcement Learning, Explainable AI, Computational Psychiatry, Antidepressant Dose Optimization, Major Depressive Disorder, Treatment Personalization, Clinical Decision Support Share and Cite: de ...

US Government Looks Abroad To Tame Medicare Drug Prices With New GUARD, GLOBE Models

CMS proposes GUARD and GLOBE models to benchmark Medicare drug prices to international levels, aiming to cut costs and reduce ...